Skip to main content
Premium Trial:

Request an Annual Quote

Phthisis Inks South Korea Distribution Deal

NEW YORK (GenomeWeb News) – Phthisis Diagnostics announced that it has signed on PhileKorea to distribute the firm's products in South Korea.

Phthisis currently offers the E-Sphere Simple NA kit for extracting nucleic acids from various sample types. It plans to eventually sell molecular diagnostics for parasites and fungi and G-Sphere Molecular Standards for laboratory quality control purposes.

"This new agreement with PhileKorea will be an important partnership as we continue to extend our distribution network in Asia and the world," Phthisis Diagnostics President and Chief Science Officer Crystal Icenhour, said in a statement. "A global network will mean faster and more accurate diagnoses for patients everywhere and it will be an important factor in the growth of our company as we can bring products to a wider market."

The new agreement follows recent distribution deals for Asia and Latin America.

The Scan

Clinical Trial Participants, Investigators Point to Importance of Clinical Trial Results Reporting in Canadian Study

Public reporting on clinical trial results is crucial, according to qualitative interviews with clinical trial participants, investigators, and organizers from three provinces appearing in BMJ Open.

Old Order Amish Analysis Highlights Autozygosity, Potential Ties to Blood Measures

Researchers in BMC Genomics see larger and more frequent runs-of-homozygosity in Old Order Amish participants, though only regional autozygosity coincided with two blood-based measures.

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.

Algorithm Teases Out Genetic Ancestry in Individuals at Biobank Scale

Researchers develop an algorithm known as Rye to tease apart ancestry fractions in admixed individuals at a biobank-scale, applying it to 488,221 UK Biobank participants in Nucleic Acids Research.